Kyowa Hakko Bio India Private Limited, a under liquidation foreign private limited company, was established on 21 December 2010 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74120MH2010FTC211152. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.25 Cr.
It upholds a compliant status. Its leadership includes Ann Chuan Goh (Managing Director), Tsuyoshi Shimose (Director), Takashi Hamai (Director). Past directors included Ryusuke Okada, Kazushige Hiramatsu, Ann Chuan Goh. Its latest AGM occurred on 25 September 2020, with the balance sheet filed on 31 March 2020. It is based at Office No 411, The Capital, Plot No C-70 G Block, Bandra Kurla Complex, Bandra(Ea, St), Mumbai, Maharashtra, 400051.
U74120MH2010FTC211152
211152
21 December 2010
₹5.00 Cr
₹3.25 Cr
Roc Mumbai
Unlisted
Under Liquidation
Explore comprehensive insights into Kyowa Hakko Bio India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ann Chuan Goh | Managing Director | 22 Mar 2018 | Current |
| Tsuyoshi Shimose | Director | 22 Mar 2018 | Current |
| Takashi Hamai | Director | 20 May 2019 | Current |
| Chikao Urata | Director | 24 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 19 Nov 2012 | Past |
| Pramod Abcsdd | Director | 02 Jan 2017 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 04 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2019 | Past |
| Pramod Abcsdd | Director | 01 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kyowa Hakko Bio India Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 24.96% increase. The company also saw a slight improvement in profitability, with a 2.18% increase in profit. The company's net worth dipped by a decrease of 1.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Kyowa Hakko Bio India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kyowa Hakko Bio India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kyowa Hakko Bio India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kyowa Hakko Bio India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Kyowa Hakko Bio India Private Limited last Annual general meeting of members was held on 25 Sep 2020 as per latest MCA records. was completed.
The activity Kyowa Hakko Bio India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was completed.
Progress on Takashi Hamai was appointed as a Director was appointed as a Director on 20 May 2019 & has been associated with this company since 6 years 6 months . was documented.
Progress on Ann Chuan Goh was appointed as a Managing Director was appointed as a Managing Director on 22 Mar 2018 & has been associated with this company since 7 years 8 months . was documented.
Tsuyoshi Shimose was appointed as a Director was appointed as a Director on 22 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
Progress on Chikao Urata was appointed as a Director was appointed as a Director on 24 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
The CIN of Kyowa Hakko Bio India Private Limited is U74120MH2010FTC211152.
Kyowa Hakko Bio India Private Limited is headquartered at Office No 411, The Capital, Plot No C-70 G Block, Bandra Kurla Complex, Bandra(Ea, St), Mumbai, Maharashtra, 400051.
Kyowa Hakko Bio India Private Limited was incorporated on 21 December 2010.
The current directors of Kyowa Hakko Bio India Private Limited are
The primary industry of Kyowa Hakko Bio India Private Limited is Pharma.
Kyowa Hakko Bio India Private Limited is unlisted.
The authorized capital of Kyowa Hakko Bio India Private Limited is ₹5.00 Cr, and the paid-up capital is ₹3.25 Cr.
The compliance status of Kyowa Hakko Bio India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX